Entera Bio Ltd.
ENTX
$1.99
$0.010.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.51% | 8.52% | 16.75% | 50.19% | -4.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.07% | 26.33% | 23.23% | 28.37% | -4.64% |
| Operating Income | -23.23% | -24.30% | -19.05% | -26.61% | 7.08% |
| Income Before Tax | -23.82% | -27.27% | -17.49% | -28.55% | 7.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.82% | -27.27% | -18.20% | -26.99% | 7.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.82% | -27.27% | -18.20% | -26.99% | 7.74% |
| EBIT | -23.23% | -24.30% | -19.05% | -26.61% | 7.08% |
| EBITDA | -23.54% | -24.69% | -19.28% | -26.90% | 6.95% |
| EPS Basic | 1.90% | -7.83% | 10.53% | 2.78% | 28.38% |
| Normalized Basic EPS | 1.94% | -7.87% | 10.93% | 1.57% | 28.37% |
| EPS Diluted | 1.90% | -7.83% | 10.53% | 2.78% | 28.38% |
| Normalized Diluted EPS | 1.94% | -7.87% | 10.93% | 1.57% | 28.37% |
| Average Basic Shares Outstanding | 26.28% | 18.08% | 32.15% | 30.65% | 28.73% |
| Average Diluted Shares Outstanding | 26.28% | 18.08% | 32.15% | 30.65% | 28.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |